Prostate Cancer in 2021: Novelties in Prognostic and Therapeutic Biomarker Evaluation

SIMPLE SUMMARY: In 2021, the identification of effective biomarkers became a major focus of prostate cancer (PCa) in order to improve outcomes and select potentially responsive patients. The aim of this contribution is to review the main 2021 novelties in prognostic and therapeutic markers in PCa, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cimadamore, Alessia, Mazzucchelli, Roberta, Lopez-Beltran, Antonio, Massari, Francesco, Santoni, Matteo, Scarpelli, Marina, Cheng, Liang, Montironi, Rodolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307279/
https://www.ncbi.nlm.nih.gov/pubmed/34298683
http://dx.doi.org/10.3390/cancers13143471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307279/
https://www.ncbi.nlm.nih.gov/pubmed/34298683
http://dx.doi.org/10.3390/cancers13143471

Ejemplares similares